ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2017
Cost of medication overuse headache in Italian patients at the time-point of withdrawal: a retrospective study based on real data.
Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Discipline-specific responses to a complex migraine case: a vignette-based survey among neurologists, psychiatrists, and family physicians.Frontiers in neurology · 2025Article
- Chronic headaches after traumatic brain injury: Diagnostic complexity associated with increased cost.NeuroRehabilitation · 2024Article
- Withdrawal failure in patients with chronic migraine and medication overuse headache.Acta neurologica Scandinavica · 2021Article
- The Ruminative Thought Style with Associated Anxiety Influences the Occurrence of Medication-Overuse Headache.Journal of clinical neurology (Seoul, Korea) · 2021Article
- Economic burden of medication-overuse headache in Iran: direct and indirect costs.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2021Article
- Evaluation of LY573144 (lasmiditan) in a preclinical model of medication overuse headache.Cephalalgia : an international journal of headache · 2020Article
- Cost of chronic and episodic migraine patients in continuous treatment for two years in a tertiary level headache Centre.The journal of headache and pain · 2019Observational
- A narrative review on the burden of migraine: when the burden is the impact on people's life.The journal of headache and pain · 2019Review
- Article
- Validation of a self-reported instrument to assess work-related difficulties in patients with migraine: the HEADWORK questionnaire.The journal of headache and pain · 2018Article
- Is Medication Overuse Drug Specific or Not? Data from a Review of Published Literature and from an Original Study on Italian MOH Patients.Current pain and headache reports · 2018Review
- Gender and education inequalities in the cost of medication-overuse headache.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2018Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The objective was to assess the cost of Medication Overuse Headache (MOH) at the time-point of withdrawal treatment. We implemented a protocol in which both direct and indirect cost were directly gathered from patients and referred to the previous three months. Direct costs were calculated by medications for acute treatment and prophylaxis, diagnostic procedures, visits, complementary treatments, informal care. Indirect costs were referred to missed workdays and workdays with reduced productivity: we asked patients to refer their salaries and to rate the overall level of performance in days worked with reduced productivity, and we calculated indirect costs on this basis. A total of 135 patients were enrolled: direct costs were around 415€/month; indirect costs were 530€/month, and were mostly due to presenteeism (350€, 66.3%) rather than to absenteeism (160€, 33.7%). Our data showed higher cost than those of a previous study: this is likely due to a different approach to cost definition, to the inclusion of direct non-medical cost, and of non-pharmacological treatments.
Indexed as
Identifiers
28527071What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.